Caxton Associates LLP Has $3.94 Million Position in Acadia Healthcare Company, Inc. $ACHC

Caxton Associates LLP raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1,234.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 173,482 shares of the company’s stock after purchasing an additional 160,482 shares during the period. Caxton Associates LLP owned 0.19% of Acadia Healthcare worth $3,936,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ACHC. Envestnet Portfolio Solutions Inc. boosted its position in shares of Acadia Healthcare by 256.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,053 shares of the company’s stock valued at $591,000 after acquiring an additional 18,742 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in Acadia Healthcare by 85.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 28,683 shares of the company’s stock valued at $651,000 after purchasing an additional 13,188 shares during the period. Janney Montgomery Scott LLC acquired a new stake in Acadia Healthcare in the 2nd quarter worth $479,000. PNC Financial Services Group Inc. increased its holdings in shares of Acadia Healthcare by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after purchasing an additional 622 shares during the period. Finally, Truist Financial Corp raised its position in shares of Acadia Healthcare by 85.6% during the second quarter. Truist Financial Corp now owns 82,741 shares of the company’s stock valued at $1,877,000 after buying an additional 38,167 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on ACHC shares. KeyCorp decreased their target price on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. Leerink Partnrs lowered Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a research note on Wednesday, December 3rd. UBS Group reduced their target price on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, December 3rd. Finally, Leerink Partners reissued a “market perform” rating and issued a $14.00 price target (down previously from $25.00) on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and a consensus target price of $23.17.

Acadia Healthcare Trading Down 1.2%

ACHC stock opened at $14.28 on Friday. The business has a fifty day moving average price of $19.53 and a 200 day moving average price of $21.38. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44. Acadia Healthcare Company, Inc. has a fifty-two week low of $12.63 and a fifty-two week high of $47.08. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of 12.21, a P/E/G ratio of 3.37 and a beta of 0.91.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. During the same period last year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.